Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/24748
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_ActivityScorpionVenomDerived.pdf2,93 MBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorGuilhelmelli, Fernanda-
dc.contributor.authorVilela, Nathália-
dc.contributor.authorSmidt, Karina S.-
dc.contributor.authorOliveira, Marco Antônio de-
dc.contributor.authorÁlvares, Alice da Cunha Morales-
dc.contributor.authorRigonatto, Maria Célia Larangeira-
dc.contributor.authorCosta, Pedro Henrique Silva-
dc.contributor.authorTavares, Aldo Henrique-
dc.contributor.authorFreitas, Sônia Maria de-
dc.contributor.authorNicola, André Moraes-
dc.contributor.authorFranco, Octávio Luiz-
dc.contributor.authorDerengowski, Lorena da Silveira-
dc.contributor.authorSchwartz, Elisabeth Nogueira Ferroni-
dc.contributor.authorMortari, Márcia Renata-
dc.contributor.authorBocca, Anamelia Lorenzetti-
dc.contributor.authorAlbuquerque, Patrícia-
dc.contributor.authorPereira, Ildinete Silva-
dc.date.accessioned2017-10-06T15:09:19Z-
dc.date.available2017-10-06T15:09:19Z-
dc.date.issued2016-11-18-
dc.identifier.citationGUILHELMELLI, Fernanda et al. Activity of scorpion venom-derived antifungal peptides against planktonic cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms. Frontiers in Microbiology, v. 7, Article 1844, 18 nov. 2016. Disponível em: <http://journal.frontiersin.org/article/10.3389/fmicb.2016.01844/full>. Acesso em: 27 jul. 2017. doi: https://doi.org/10.3389/fmicb.2016.01844.pt_BR
dc.identifier.urihttp://repositorio.unb.br/handle/10482/24748-
dc.language.isoInglêspt_BR
dc.publisherFrontierspt_BR
dc.rightsAcesso Abertopt_BR
dc.titleActivity of scorpion venom-derived antifungal peptides against planktonic cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilmspt_BR
dc.typeArtigopt_BR
dc.subject.keywordInfecção - fungospt_BR
dc.subject.keywordEscorpião - venenopt_BR
dc.subject.keywordTratamentopt_BR
dc.rights.licenseCopyright © 2016 Guilhelmelli, Vilela, Smidt, de Oliveira, Álvares, Rigonatto, da Silva Costa, Tavares, Freitas, Nicola, Franco, Derengowski, Schwartz, Mortari, Bocca, Albuquerque and Silva-Pereira. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.pt_BR
dc.identifier.doihttps://doi.org/10.3389/fmicb.2016.01844pt_BR
dc.description.abstract1The incidence of fungal infections has been increasing in the last decades, while the number of available antifungal classes remains the same. The natural and acquired resistance of some fungal species to available therapies, associated with the high toxicity of these drugs on the present scenario and makes an imperative of the search for new, more efficient and less toxic therapeutic choices. Antimicrobial peptides (AMPs) are a potential class of antimicrobial drugs consisting of evolutionarily conserved multifunctional molecules with both microbicidal and immunomodulatory properties being part of the innate immune response of diverse organisms. In this study, we evaluated 11 scorpion-venom derived non-disulfide-bridged peptides against Cryptococcus neoformans and Candida spp., which are important human pathogens. Seven of them, including two novel molecules, showed activity against both genera with minimum inhibitory concentration values ranging from 3.12 to 200 μM and an analogous activity against Candida albicans biofilms. Most of the peptides presented low hemolytic and cytotoxic activity against mammalian cells. Modifications in the primary peptide sequence, as revealed by in silico and circular dichroism analyses of the most promising peptides, underscored the importance of cationicity for their antimicrobial activity as well as the amphipathicity of these molecules and their tendency to form alpha helices. This is the first report of scorpion-derived AMPs against C. neoformans and our results underline the potential of scorpion venom as a source of antimicrobials. Further characterization of their mechanism of action, followed by molecular optimization to decrease their cytotoxicity and increase antimicrobial activity, is needed to fully clarify their real potential as antifungals.pt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.